Sarcopenic Obesity Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting sarcopenic obesity clinical trials across 5 countries. Studies span Not Applicable, Phase 4. Top locations include Baton Rouge, Louisiana, United States, Hong Kong, Hong Kong, Milan, Italy. Updated daily from ClinicalTrials.gov.


Sarcopenic Obesity Trials at a Glance

11 actively recruiting trials for sarcopenic obesity are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Baton Rouge, Hong Kong, and Milan. Lead sponsors running sarcopenic obesity studies include Dr. David Scott, Elisa Giannetta, and Deakin University.

Browse sarcopenic obesity trials by phase

Treatments under study

About Sarcopenic Obesity Clinical Trials

Looking for clinical trials for Sarcopenic Obesity? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Sarcopenic Obesity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Sarcopenic Obesity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 4

GLP-1R Actions on Muscle and the Skeleton

ObesityOsteoporosisDrug Effect+2 more
Pennington Biomedical Research Center50 enrolled1 locationNCT07154719
Recruiting
Not Applicable

Adverse Outcomes and Mortality in Liver Transplant

SarcopeniaCirrhosisEnd Stage Liver Disease+1 more
Mayo Clinic100 enrolled1 locationNCT05477277
Recruiting

Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly

Sarcopenic Obesity
IRCCS San Raffaele1,108 enrolled1 locationNCT06320158
Recruiting

Pilot Study of the Human Metagenome in Metabolic Diseases

SarcopeniaObesityMetabolic Syndrome+2 more
Sengkang General Hospital600 enrolled1 locationNCT06363253
Recruiting
Not Applicable

Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study

Heart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Reduced Ejection FractionSarcopenic Obesity+1 more
Universita di Verona15 enrolled2 locationsNCT06826963
Recruiting
Not Applicable

Effects of the EatWelLog App on Diet Management for Older Adults With Sarcopenic Obesity

Sarcopenic Obesity
The Hong Kong Polytechnic University40 enrolled1 locationNCT06360432
Recruiting

Prevalence of Sarcopenic Obesity in COPD

COPDSarcopenic Obesity
IRCCS San Raffaele Roma236 enrolled1 locationNCT06822504
Recruiting

Validation of an Algorithm for the Diagnosis of Sarcopenic Obesity

Sarcopenic Obesity
Elisa Giannetta150 enrolled1 locationNCT06815978
Recruiting

Assessing effectiveness of Weight loss and Exercise programs for older adults with Sarcopenic Obesity delivered via MobilE application/s

Sarcopenic Obesity
Deakin University116 enrolled1 locationACTRN12621000236897
Recruiting

Osteogenic Exercise for Musculoskeletal and Metabolic Health during Weight Loss in Sarcopenic Obese Older Adults: A Pilot Study (OSMOSIS-P)

Metabolic HealthSarcopenic Obesity
Dr. David Scott60 enrolled1 locationACTRN12618001146280
Recruiting

The Exercise for the Prevention of Falls in Older Adults with Sarcopenic Obesity Pilot Study (ESPRESSO-P).

Falls RiskSarcopenic Obesity
Dr. David Scott56 enrolled1 locationACTRN12618000192280